Xconomy National

Archives

by in

Entry	Author	Date	Location
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy	Bruce V. Bigelow	02/03/12	San Diego
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News	Erin Kutz	02/03/12	Boston
Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug	Luke Timmerman	01/27/12	National
Novo Nordisk Adds Diabetes Research to Seattle Immunology Team	Luke Timmerman	01/23/12	Seattle
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting	Luke Timmerman	01/23/12	National
San Diego Life Sciences News: AnaptysBio, Life, NeuroGenetic & More	Bruce V. Bigelow	01/12/12	San Diego
Cebix to Raise $20 Million for Pivotal Trial of Diabetes Supplement	Bruce V. Bigelow	01/10/12	San Diego
Cure for Diabetes	Bryan Roberts	12/28/11	San Francisco
Alkermes Spinoff, Civitas, Gets Michael J. Fox Support for Inhalable Parkinson’s Drug	Luke Timmerman	11/29/11	Boston
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 2)	Luke Timmerman	11/22/11	National
FDA Clears Portable Insulin Pump from San Diego’s Tandem Diabetes	Bruce V. Bigelow	11/16/11	San Diego
Turnaround CEO Shores Up Strategy for Unigene Based on Big Pharma Partnerships	Arlene Weintraub	11/15/11	New York
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News	Bruce V. Bigelow	11/10/11	San Diego
Merck Unveils Alzheimer’s and Diabetes Projects, Personnel Changes	Arlene Weintraub	11/10/11	New York
Rhythm Adds Former Merck VP as CEO	Erin Kutz	11/09/11	Boston
Amylin and Eli Lilly Part Ways on Diabetes Drug; Alkermes Deal Intact	Bruce V. Bigelow	11/08/11	San Diego
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News	Erin Kutz	10/28/11	Boston
BIND and Selecta Pull in $50M from Russian Fund Seeking to Advance Nano-Drugs	Arlene Weintraub	10/27/11	Boston
MPM-Backed Rhythm Advances Drug Programs in Diabetes and Obesity	Arlene Weintraub	10/25/11	Boston
Catabasis Begins Human Trials of Omega-3-Inspired Diabetes Treatment	Arlene Weintraub	10/20/11	Boston
Sofinnova Ventures Defies the Grim Mood, Raises $440M For Biotech-Only VC Fund	Luke Timmerman	10/17/11	San Francisco
Tolerx Shutters, Courtagen Gets $8M, OvaScience Emerges, & More Boston-Area Life Sciences News	Erin Kutz	10/14/11	Boston
Report: Tolerx Folds Its Tent, After $150M in Investment and a Failed Diabetes Drug Trial	Luke Timmerman	10/07/11	Boston
Sangamo Fails Diabetic Neuropathy Study, Falls Back on HIV, Other Programs	Luke Timmerman	10/03/11	San Francisco
Elevation Partners Grabs $17M, NanoSort Wins Grants, NIH Collaborates with Afraxis on Rare Disease R&D, & More San Diego Life Sciences News	Bruce V. Bigelow	09/29/11	San Diego
AdverseEvents.com Seeks to Keep Track of Drug Side Effects the Way the FDA Never Could	Luke Timmerman	09/27/11	San Francisco
Tensha Nabs $15M, Termeer Gives MIT $10M, Stata Puts $10M Into NABsys, & More Boston-Area Life Sciences News	Erin Kutz	09/16/11	Boston
GI Dynamics Starts Trading on Aussie Exchange, Eyes U.S. Pilot Study for Device in Diabetes and Obesity	Arlene Weintraub	09/14/11	Boston
Valeritas Raises $150M for Insulin Device	Arlene Weintraub	09/13/11	New York
Pfizer Grows in Cambridge, Repligen Eyes Imaging Approval, GI Dynamics Gets Aussie IPO, & More Boston-Area Life Sciences News	Erin Kutz	09/02/11	Boston
Page 1 of 9	next page »